HCTI
Healthcare Triangle, Inc.NASDAQHealthcare$2.44-3.17%ClosedMarket Cap: $2.8M
As of 2026-04-09
Valuation
P/E (TTM)
—
PEG
—
P/B
0.00
P/S
0.22
EV/EBITDA
-0.51
DCF Value
$-20,578.18
FCF Yield
-418.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
13.1%
Operating Margin
-47.9%
Net Margin
-48.9%
ROE
-112.8%
ROA
-45.7%
ROIC
-54.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 2025 | $3.5M | 17.7% | $-2.6M | $-1.9M | $-5,394.86 | — |
| Q2 2025 | $3.6M | 13.9% | $-1.4M | $-1.4M | $-3,872.07 | — |
| Q1 2025 | $3.7M | 8.9% | $-1.4M | $-1.7M | $-4,811.78 | — |
| Q4 2024 | $2.2M | 11.7% | $-852.0K | $-1.3M | $-3,553.89 | — |
| FY 2024 | $11.7M | 24.7% | $-4.8M | $-6.0M | $-16,895.00 | — |
| Q3 2024 | $2.4M | 29.9% | $-1.2M | $-1.2M | $-3,293.20 | — |
| Q2 2024 | $3.0M | 12.2% | $-1.4M | $-1.5M | $-4,243.38 | — |
| Q1 2024 | $4.1M | 11.6% | $-1.7M | $-1.9M | $-6,243.94 | — |
| Q4 2023 | $7.1M | 21.7% | $-479.0K | $-1.7M | $-5,821.61 | — |
| FY 2023 | $33.2M | 20.4% | $-7.7M | $-8.7M | $-31,051.00 | — |
| Q3 2023 | $7.8M | 12.8% | $-1.5M | $-1.9M | $-6,865.20 | — |
| Q2 2023 | $8.5M | 13.4% | $-1.6M | $-1.8M | $-6,310.42 | — |